Iopamidol clinical trials
Also written Isovue.
How each study uses Iopamidol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 31 Dec 1985 · ISOVUE-250 · NDA 018735 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 5
Bracco Diagnostics, Inc (5) · Duke University (3) · Stanford University (1) · Azienda Policlinico Umberto I (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Iopamidol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Thyroid Function of Pediatric Subjects Following Isovue® AdministrationTerminatedPhase 4Bracco Diagnostics, IncNCT03779906Written as IsovueHow we know
- CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation TherapyCompletedPhase 1Stanford UniversityNCT02693080Written as Isovue-200How we know
- INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological CancersCompletedEarly Phase 1Duke UniversityNCT03071328Written as Isovue-M 200How we know
- Thoracoabdominal Arortic CTA StudyCompletedPhase 4Duke UniversityNCT02291718Written as IsovueHow we know
- Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)CompletedPhase 3Duke UniversityNCT02171247Written as Isovue 370How we know
- Low-dose Laxative Improves Performance and Feasibility of Computed Tomography Colonography (CTC)CompletedPhase 4Azienda Policlinico Umberto INCT02040285Written as Bisacodyl & PEG-CSHow we know
- Isovue in Peripheral Digital Subtraction Angiography (DSA)CompletedPhase 4Bracco Diagnostics, IncNCT01075217Written as iopamidolHow we know
- Coronary MDCTA With Iopamidol Injection 370CompletedPhase 2Bracco Diagnostics, IncNCT00558792Written as Isovue 370, 70 mLHow we know
- Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSACompletedPhase 4Bracco Diagnostics, IncNCT00740207Written as Isovue 250How we know
- Detection of Pulmonary Embolism With CECTCompletedPhase 4Bracco Diagnostics, IncNCT00351754Written as IsovueHow we know
Given beside what is tested · 1 — Iopamidol is usual care or a partner of the new treatment
Codes
What other systems call Iopamidol · ClinicalTrials.gg INT007682
- MeSH (NLM) D007479IopamidolConfirmed NLM, Wikidata
- UNII (FDA) JR13W81H44IOPAMIDOLConfirmed FDA, NLM, Wikidata
- RxNorm 5966Confirmed FDA, Wikidata
- Wikidata Q424788iopamidolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47567IopamidolOne source FDA
- DrugBank DB08947One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007479 | Iopamidol | Confirmed NLM, Wikidata |
| UNII (FDA) | JR13W81H44 | IOPAMIDOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 5966 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424788 | iopamidol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47567 | Iopamidol | One source FDA |
| DrugBank | DB08947 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.